Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
The move signals a major expansion in access to next-generation weight-loss therapies
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
